Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid Leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors حسب Mohamed A. Ismail (418629)

مؤلفون آخرون:

Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients حسب Mohamed A. Ismail (418629)

مؤلفون آخرون:

Aberrant DNA methylation of <i>PTPRG</i> as one possible mechanism of its under‐expression in CML patients in the State of Qatar حسب Mohamed A. Ismail (418629)

مؤلفون آخرون: